NUR 590 Topic 6 evaluation section with baseline example

Evidence-Based Practice Project Grand Canyon University Free custom sample in 24 to 48h

This NUR 590 Topic 6 sample paper writes the evaluation section for the potassium protocol pilot, starting from a baseline that already exists in a completed audit. It was written for GCU NUR 590, Evidence-Based Practice Project, catalog code NUR-590, which nurses take in the MSN at Grand Canyon University. The baseline uses record time stamps for result and administration. The target, a median of 1.5 hours or less, is justified from the two Level II protocol studies. Process and outcome measures are separated. Skewed times call for medians and run charts, after Perla and colleagues. Owners are assigned, and what about 55 patients over ten weeks can show is stated.

CourseNUR 590 Evidence-Based Practice Project
TopicTopic 6
Paper typeProject evaluation plan
LengthAbout 1,000 words, 3 pages
FormatAPA 7 student paper
SchoolGrand Canyon University (GCU)
ProgramMSN
UpdatedOctober 2026

Free sample paper for NUR 590 Topic 6

1

Starting From a Number That Already Exists: The Evaluation Section for the Potassium Protocol Pilot

[Author Name]

College of Nursing and Health Care Professions, Grand Canyon University

NUR-590: Evidence-Based Practice Project

Topic 6 Assignment

[Instructor Name]

June 18, 2029

The organization, setting and figures below are a composite written as a model document. No real employer, client, colleague or patient is described.

What this page is doingThe title states where the evaluation begins: with a baseline already measured, reported with its source, window and method. The target is justified from appraised evidence, process and outcome measures are separated, the analysis is matched to the data and sample size, and the section is honest about what a ten-week pilot can show. The floor and figures are composites.
2

Starting From a Number That Already Exists: The Evaluation Section for the Potassium Protocol Pilot

The Baseline

The baseline comes from the audit already completed. Source: the electronic record, using the time stamp when each potassium result posted and the administration time charted for the first replacement dose. Window: the 13 weeks from February 5 to May 5, 2029. Method: the quality analyst extracted every adult on 5 West whose morning potassium result was low; I reviewed each chart to confirm eligibility against the protocol's criteria and to record the route and any diuretic or digoxin given before replacement. Of 118 patients with low potassium, 74 fell inside the protocol's range and had normal kidney function. For those 74, the median time from result to first dose was 3.2 hours, with an interquartile range of 2.1 to 5.0 hours; 18 of 74, or 24 percent, received a scheduled loop diuretic or digoxin before replacement; and 21, or 28 percent, received intravenous potassium without a documented reason.

The Target, Justified

The primary target is a median time to first dose of 1.5 hours or less for protocol-eligible patients during the pilot. It is not chosen for roundness. In a medical intensive care unit, a replacement protocol reduced the median time to the potassium dose from 180 to 98 minutes, a reduction of about 46 percent (Pearson et al., 2018). A similar proportional reduction from the floor's baseline of 3.2 hours would give about 1.7 hours. The floor's target is somewhat more ambitious, because oral potassium stocked on the unit removes the pharmacy preparation and delivery time that intravenous replacement requires. A prospective ICU comparison found an even larger effect, from 161 to 19 minutes (Hijazi & Al-Ansari, 2005), but that setting's nurse staffing makes it an unrealistic benchmark for a floor. The secondary target is to reduce diuretic or digoxin doses given before replacement from 24 percent to 10 percent or less.

Process and Outcome Measures, Separated

Outcome measures: median time from result to first dose; percentage of eligible patients receiving a diuretic or digoxin before replacement; and, as a safety outcome, the number of patients with a repeat potassium above 5.0 mEq/L after protocol replacement.

Process measures: the percentage of protocol-eligible patients whose replacement was actually initiated under the protocol; the percentage of protocol replacements given orally; and the percentage with a repeat potassium level drawn at the specified time.

The process measure that will explain a null result is the first: if the median time does not fall, the floor must know whether the protocol was used and failed to speed replacement, or was simply not used, because those call for opposite responses, revising the protocol or revising its implementation.

What this page is doingThe baseline is reported with its source, window and method, and the target is derived from appraised studies rather than chosen for roundness. The highlighted sentence identifies which process measure will explain a null result and why that distinction matters.
3

Analysis Matched to the Data

Time to first dose is skewed: most patients wait one to four hours, but a few wait much longer. Means would be pulled by those few, so the evaluation reports medians and interquartile ranges, and compares the baseline and pilot periods with the Mann-Whitney U test, which does not assume a normal distribution. Proportions, such as diuretic or digoxin given before replacement, are compared with a chi-square test, or Fisher's exact test if any expected cell count is below five.

Because the pilot is short and a single comparison of two periods can hide a trend that was already under way, each week's median goes onto a run chart and the pre-pilot median drawn across the chart as its reference line. Run chart rules, such as six or more consecutive points below the median, identify a nonrandom change even with small numbers each week (Perla et al., 2011).

Who Collects What, and When

Each measure has an owner so that data collection does not depend on the project lead remembering. The quality analyst runs the time-to-dose report every Monday for the previous week, using the same query as the baseline so the two periods are measured identically. The clinical pharmacist, who verifies every protocol order each morning, records whether it was oral or intravenous and whether the repeat level was ordered, in a shared log. The charge nurse flags any patient who received a diuretic or digoxin before replacement at the morning huddle, and I confirm each flag against the chart weekly. Any repeat potassium above 5.0 mEq/L generates an automatic laboratory notification to the pharmacist and to me the same day, so the safety stopping rule can be applied without waiting for the weekly report.

Collecting data this way adds about an hour a week for the quality analyst and a few minutes a day for the pharmacist and charge nurse, all within the time costed in the implementation plan. Using the same extraction method in both periods matters more than any statistical test: if the pilot were measured differently from the baseline, a change in the numbers could reflect the method rather than the protocol.

What the Sample Can and Cannot Show

The pilot is expected to include about 55 protocol-eligible patients over ten weeks. That is enough to detect a large change in median time, such as the one targeted, with reasonable confidence. It is not enough to claim that the change in diuretic or digoxin timing is statistically significant unless the change is large, and the evaluation will report the proportion and its confidence interval rather than a significance claim it cannot support. It is far too small to show any effect on arrhythmias, which the project does not measure as an outcome, or to establish safety conclusively; the safety measure is monitored to detect harm, not to prove its absence. Any hyperkalemia event triggers the stopping rule regardless of statistics.

The comparison is before and after, without a concurrent control unit, so the evaluation will report other changes during the pilot, such as the hospitalist group's new rounding schedule in August, that could affect time to replacement. If time to replacement falls in the first weeks, before that change, the run chart will show it.

References

Hijazi, M., & Al-Ansari, M. (2005). Protocol-driven vs. physician-driven electrolyte replacement in adult critically ill patients. Annals of Saudi Medicine, 25(2), 105-110. https://doi.org/10.5144/0256-4947.2005.105

Pearson, D. J., Sharma, A., Lospinoso, J. A., Morris, M. J., & McCann, E. T. (2018). Effects of electrolyte replacement protocol implementation in a medical intensive care unit. Journal of Intensive Care Medicine, 33(10), 574-581. https://doi.org/10.1177/0885066616679593

Perla, R. J., Provost, L. P., & Murray, S. K. (2011). The run chart: A simple analytical tool for learning from variation in healthcare processes. BMJ Quality & Safety, 20(1), 46-51. https://doi.org/10.1136/bmjqs.2009.037895

Reading the GCU NUR 590 Topic 6 instructions

Topic 6 in NUR-590 asks students to plan the evaluation of their project. Strong plans start from a baseline with a stated source, set a target justified by the evidence rather than chosen for roundness and separate process measures, which show whether the change was carried out, from outcome measures, which show whether it worked. Students should match the analysis to the data, for example medians and run charts for skewed times, assign an owner to each measure and state what the expected sample can and cannot show. Statistical significance is usually not the standard for a project of this size, and the plan should say what would count as success in practical terms. Targets need sources.

Inside the NUR 590 Topic 6 example

The finished example opens with a number that already exists. The baseline is reported with its source, its time window and its collection method, because a target set against an unmeasured present cannot demonstrate anything afterward. The target follows and is justified rather than chosen for roundness, usually from what the appraised studies achieved or from a published benchmark. Measures are separated into process and outcome, with the process measure identified as the one that will explain a null result. The analysis is named and matched to the data, and the example is honest that a small project may not reach statistical significance and that a clinically meaningful change is the more useful test.

Reading the NUR 590 Topic 6 rubric

Faculty reward an evaluation matched to its data. An Excellent plan takes its baseline from record time stamps and sets a median target of 1.5 hours justified by the two Level II protocol studies. Credit goes to separating process measures, such as protocol use, from outcomes such as time to first dose. The rubric values medians and run charts for skewed times, after Perla and colleagues. Strong plans assign each measure to an owner, such as the quality analyst. Top marks go to stating what about 55 patients over ten weeks can show. Owners are named. Limits are stated.

Common NUR 590 Topic 6 mistakes, and how to avoid them

Targets with no baseline are exactly what this topic is written to catch, and the course drawer line for this topic says so outright. A promise to reduce something by twenty percent means nothing until the reader knows twenty percent of what. The second loss is a target chosen because it sounds ambitious, with no derivation from the evidence or from a benchmark. Papers lose marks for outcome measures alone, which leaves a failed project unable to say why. Naming a statistical test that does not suit the data is a technical error faculty check. Claiming significance is expected from a sample of thirty is a power claim the project cannot support.

Get an NUR-590 Topic 6 example written to your instructions

Send the NUR-590 Topic 6 instructions and the rubric from your classroom, with whatever your setting already measures and the target your intervention is aiming at. We write a custom example to those criteria, with the baseline sourced and stated first, the target derived from evidence and the analysis matched to your data, in 24 to 48 hours. The first is free.

More NUR 590 papers and MSN samples

NUR 590 Topic 6 questions, answered

What if my setting has no baseline data?

Collect it, and build the collection into the project as its first activity. Two weeks of counting before the intervention starts is a legitimate and often necessary opening phase, and it is far stronger than an estimate. Say how you would collect it, over what period and by whom, since a proposal that plans its own baseline reads as more competent than one that assumes a figure exists.

How do I choose a target?

From your evidence table wherever possible. If the studies you appraised achieved a reduction of a certain size in comparable settings, that is a defensible target with a citation attached. A published benchmark works too. What loses marks is a round number chosen because it sounds convincing, since a reviewer will ask where it came from and there will be no answer.

Does my project need to reach statistical significance?

Usually not, and claiming it will is often the weaker position. Projects of this size are frequently underpowered, and a clinically meaningful change in a process measure can matter to a floor whatever a test reports. Say what your sample can realistically detect, report descriptive results honestly, and treat significance as one piece of evidence rather than as the verdict.

Where can I find a free NUR 590 Topic 6 sample paper?

The evaluation section for NUR 590 Topic 6 covers the baseline, the target justified, process and outcome measures separated, analysis matched to the data, who collects what and when and what the sample can and cannot show. Paste in your NUR 590 Topic 6 prompt and a free plan follows.

Does the project need statistical significance in NUR 590 Topic 6?

Usually not. With about 55 patients, the evaluation looks for a large, sustained shift on a run chart rather than a test of significance.